Cargando…

How do we evaluate outcome in an integrative oncology program?

Integrative oncology focuses on the roles of complementary therapies to increase the effectiveness of conventional cancer treatment programs by improving defined outcomes such as symptom control, quality of life, rehabilitation, and prevention of recurrence. Implementation of integrative oncology pr...

Descripción completa

Detalles Bibliográficos
Autor principal: Sagar, S.M.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528566/
https://www.ncbi.nlm.nih.gov/pubmed/18769584
_version_ 1782158882645213184
author Sagar, S.M.
author_facet Sagar, S.M.
author_sort Sagar, S.M.
collection PubMed
description Integrative oncology focuses on the roles of complementary therapies to increase the effectiveness of conventional cancer treatment programs by improving defined outcomes such as symptom control, quality of life, rehabilitation, and prevention of recurrence. Implementation of integrative oncology programs should be based on the best evidence and must continually be evaluated to ensure quality, optimization of techniques, collection of new data, and cost-effectiveness. Useful domains that can be evaluated include symptom control, adherence to treatment protocols, quality of life, individual outcomes, prevention, rehabilitation, potential advantages of a whole-systems health approach, and economics of health services.
format Text
id pubmed-2528566
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Multimed Inc.
record_format MEDLINE/PubMed
spelling pubmed-25285662008-09-03 How do we evaluate outcome in an integrative oncology program? Sagar, S.M. Curr Oncol Integrative Oncology Integrative oncology focuses on the roles of complementary therapies to increase the effectiveness of conventional cancer treatment programs by improving defined outcomes such as symptom control, quality of life, rehabilitation, and prevention of recurrence. Implementation of integrative oncology programs should be based on the best evidence and must continually be evaluated to ensure quality, optimization of techniques, collection of new data, and cost-effectiveness. Useful domains that can be evaluated include symptom control, adherence to treatment protocols, quality of life, individual outcomes, prevention, rehabilitation, potential advantages of a whole-systems health approach, and economics of health services. Multimed Inc. 2008-08 /pmc/articles/PMC2528566/ /pubmed/18769584 Text en 2008 Multimed Inc. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Integrative Oncology
Sagar, S.M.
How do we evaluate outcome in an integrative oncology program?
title How do we evaluate outcome in an integrative oncology program?
title_full How do we evaluate outcome in an integrative oncology program?
title_fullStr How do we evaluate outcome in an integrative oncology program?
title_full_unstemmed How do we evaluate outcome in an integrative oncology program?
title_short How do we evaluate outcome in an integrative oncology program?
title_sort how do we evaluate outcome in an integrative oncology program?
topic Integrative Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528566/
https://www.ncbi.nlm.nih.gov/pubmed/18769584
work_keys_str_mv AT sagarsm howdoweevaluateoutcomeinanintegrativeoncologyprogram